ATM/RB1 mutations predict shorter overall survival in urothelial cancer

BACKGROUND: Mutations of DNA repair genes, e.g. ATM/RB1, are frequently found in urothelial cancer (UC) and have been associated with better response to cisplatin-based chemotherapy. Further external validation of the prognostic value of ATM/RB1 mutations in UC can inform clinical decision making an...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Yin, Ming, Grivas, Petros, Emamekhoo, Hamid, Mendiratta, Prateek, Ali, Siraj, Hsu, JoAnn, Vasekar, Monali, Drabick, Joseph J., Pal, Sumanta, Joshi, Monika
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2018
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5908293/
https://ncbi.nlm.nih.gov/pubmed/29682192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24738
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires